Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Vrk2 | Rat | (+)-catechin | multiple interactions | ISO | VRK2 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of VRK2 mRNA | CTD | PMID:24763279 | Vrk2 | Rat | (S)-nicotine | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Nicotine results in decreased expression of VRK2 mRNA | CTD | PMID:23825647 | Vrk2 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Vrk2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of VRK2 mRNA | CTD | PMID:22206623 | Vrk2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Vrk2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of VRK2 mRNA | CTD | PMID:21570461 | Vrk2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of VRK2 mRNA | CTD | PMID:33387578 | Vrk2 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Vrk2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of VRK2 mRNA | CTD | PMID:28973697 | Vrk2 | Rat | acrylamide | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of VRK2 mRNA | CTD | PMID:32763439 | Vrk2 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of VRK2 mRNA | CTD | PMID:23630614 | Vrk2 | Rat | aflatoxin B1 | increases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of VRK2 mRNA | CTD | PMID:27153756 | Vrk2 | Rat | aflatoxin B1 | decreases methylation | ISO | VRK2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of VRK2 gene | CTD | PMID:27153756 | Vrk2 | Rat | all-trans-retinoic acid | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of VRK2 mRNA | CTD | PMID:15498508 | Vrk2 | Rat | antirheumatic drug | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of VRK2 mRNA | CTD | PMID:24449571 | Vrk2 | Rat | aristolochic acid A | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of VRK2 mRNA | CTD | PMID:33212167 | Vrk2 | Rat | benzo[a]pyrene | increases expression | ISO | Vrk2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of VRK2 mRNA | CTD | PMID:22228805 | Vrk2 | Rat | benzo[a]pyrene | multiple interactions | ISO | Vrk2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VRK2 mRNA | CTD | PMID:27858113 | Vrk2 | Rat | benzo[b]fluoranthene | multiple interactions | ISO | Vrk2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VRK2 mRNA | CTD | PMID:27858113 | Vrk2 | Rat | bisphenol A | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of VRK2 mRNA | CTD | PMID:20678512 | Vrk2 | Rat | bisphenol A | affects methylation | ISO | VRK2 (Homo sapiens) | 6480464 | bisphenol A affects the methylation of VRK2 gene | CTD | PMID:31601247 | Vrk2 | Rat | bisphenol A | affects expression | ISO | VRK2 (Homo sapiens) | 6480464 | bisphenol A affects the expression of VRK2 mRNA | CTD | PMID:30903817 | Vrk2 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of VRK2 gene | CTD | PMID:28505145 | Vrk2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of VRK2 mRNA | CTD | PMID:25181051 | Vrk2 | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of VRK2 mRNA | CTD | PMID:33453195 | Vrk2 | Rat | cadmium dichloride | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of VRK2 mRNA | CTD | PMID:38568856 | Vrk2 | Rat | cadmium dichloride | increases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of VRK2 mRNA | CTD | PMID:26472689 | Vrk2 | Rat | carbon nanotube | increases expression | ISO | Vrk2 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of VRK2 mRNA | CTD | PMID:25554681 | Vrk2 | Rat | CGP 52608 | multiple interactions | ISO | VRK2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to VRK2 gene] | CTD | PMID:28238834 | Vrk2 | Rat | chlorpyrifos | increases expression | ISO | Vrk2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of VRK2 mRNA | CTD | PMID:32715474 | Vrk2 | Rat | chrysene | multiple interactions | ISO | Vrk2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VRK2 mRNA | CTD | PMID:27858113 | Vrk2 | Rat | copper(II) sulfate | increases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of VRK2 mRNA | CTD | PMID:19549813 | Vrk2 | Rat | cyclosporin A | increases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of VRK2 mRNA | CTD | PMID:20106945 and PMID:25562108 | Vrk2 | Rat | cytarabine | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Cytarabine results in decreased expression of VRK2 mRNA | CTD | PMID:21198554 | Vrk2 | Rat | DDE | increases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of VRK2 mRNA | CTD | PMID:38568856 | Vrk2 | Rat | DDT | decreases methylation | EXP | | 6480464 | DDT results in decreased methylation of VRK2 gene | CTD | PMID:30207508 | Vrk2 | Rat | Dibutyl phosphate | affects expression | ISO | VRK2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of VRK2 mRNA | CTD | PMID:37042841 | Vrk2 | Rat | dibutyl phthalate | decreases expression | ISO | Vrk2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of VRK2 mRNA | CTD | PMID:21266533 | Vrk2 | Rat | dicrotophos | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of VRK2 mRNA | CTD | PMID:28302478 | Vrk2 | Rat | doxorubicin | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of VRK2 mRNA | CTD | PMID:29803840 | Vrk2 | Rat | epoxiconazole | increases expression | ISO | Vrk2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of VRK2 mRNA | CTD | PMID:35436446 | Vrk2 | Rat | folic acid | multiple interactions | ISO | Vrk2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of VRK2 mRNA | CTD | PMID:22206623 | Vrk2 | Rat | FR900359 | decreases phosphorylation | ISO | VRK2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of VRK2 protein | CTD | PMID:37730182 | Vrk2 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of VRK2 mRNA | CTD | PMID:25539665 | Vrk2 | Rat | glycidyl methacrylate | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | glycidyl methacrylate results in decreased expression of VRK2 protein | CTD | PMID:36641056 | Vrk2 | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of VRK2 mRNA | CTD | PMID:21396975 | Vrk2 | Rat | N-nitrosodimethylamine | increases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Dimethylnitrosamine results in increased expression of VRK2 mRNA | CTD | PMID:17547211 | Vrk2 | Rat | nicotine | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Nicotine results in decreased expression of VRK2 mRNA | CTD | PMID:23825647 | Vrk2 | Rat | phenobarbital | affects expression | ISO | VRK2 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of VRK2 mRNA | CTD | PMID:19159669 | Vrk2 | Rat | phenol | increases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Phenol results in increased expression of VRK2 mRNA | CTD | PMID:17547211 | Vrk2 | Rat | pirinixic acid | multiple interactions | ISO | Vrk2 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of VRK2 mRNA | CTD | PMID:19710929 | Vrk2 | Rat | piroxicam | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Piroxicam results in decreased expression of VRK2 mRNA | CTD | PMID:21858171 | Vrk2 | Rat | protein kinase inhibitor | multiple interactions | ISO | VRK2 (Homo sapiens) | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of VRK2 mRNA] | CTD | PMID:28003376 | Vrk2 | Rat | quercetin | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of VRK2 mRNA | CTD | PMID:15309432 and PMID:21632981 | Vrk2 | Rat | sunitinib | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of VRK2 mRNA | CTD | PMID:31533062 | Vrk2 | Rat | tamibarotene | affects expression | ISO | VRK2 (Homo sapiens) | 6480464 | tamibarotene affects the expression of VRK2 mRNA | CTD | PMID:15498508 | Vrk2 | Rat | temozolomide | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of VRK2 mRNA | CTD | PMID:31758290 | Vrk2 | Rat | tetraphene | multiple interactions | ISO | Vrk2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VRK2 mRNA | CTD | PMID:27858113 | Vrk2 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of VRK2 mRNA | CTD | PMID:23411599 | Vrk2 | Rat | titanium dioxide | decreases expression | ISO | Vrk2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of VRK2 mRNA | CTD | PMID:29264374 | Vrk2 | Rat | titanium dioxide | decreases methylation | ISO | Vrk2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of VRK2 gene | CTD | PMID:35295148 | Vrk2 | Rat | trichostatin A | decreases expression | ISO | VRK2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of VRK2 mRNA | CTD | PMID:24935251 | Vrk2 | Rat | trichostatin A | affects expression | ISO | VRK2 (Homo sapiens) | 6480464 | trichostatin A affects the expression of VRK2 mRNA | CTD | PMID:28542535 | Vrk2 | Rat | triphenyl phosphate | affects expression | ISO | VRK2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of VRK2 mRNA | CTD | PMID:37042841 | Vrk2 | Rat | triptonide | decreases expression | ISO | Vrk2 (Mus musculus) | 6480464 | triptonide results in decreased expression of VRK2 mRNA | CTD | PMID:33045310 | Vrk2 | Rat | valproic acid | decreases methylation | ISO | VRK2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of VRK2 gene | CTD | PMID:29154799 | Vrk2 | Rat | valproic acid | affects expression | ISO | VRK2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of VRK2 mRNA | CTD | PMID:25979313 | Vrk2 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of VRK2 mRNA | CTD | PMID:22570695 | |